D.E. Shaw & Co
RXST icon

D.E. Shaw & Co’s RxSight RXST Stock Holding History

D.E. Shaw & Co’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,400
Closed -$267K – 4805
2024
Q3 		$267K Sell
5,400
-2,300
-30% -$118K ﹤0.01% 4032
2024
Q2 		$463K Buy
+7,700
New +$440K ﹤0.01% 3665

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co's RXST Position: Q1 2026 in Review

D.E. Shaw & Co increased its RxSight (RXST) stake by 4% in Q1 2026, buying an estimated $630K and bringing the position to 1,959,732 shares worth $12.1M. The position accounts for 0.01% of the portfolio, ranked #1488.

D.E. Shaw & Co first reported a position in RXST in Q2 2023 and has held it in 12 quarters since. The position peaked at $19.6M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • D.E. Shaw & Co held 1,959,732 shares of RxSight worth $12.1M as of Q1 2026.
  • D.E. Shaw & Co bought 75,903 RxSight shares in Q1 2026, an estimated $630K.
  • RxSight made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1488 holding.
  • D.E. Shaw & Co first reported a position in RxSight in Q2 2023 and has held it in 12 quarters since.
  • D.E. Shaw & Co's RxSight position peaked at $19.6M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.